Who are fluticasone furoate, fexofenadine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Fluticasone/Azelastine nasal spray.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/fluticasone-furoate-fexofenadine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

fluticasone furoate, fexofenadine — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

fluticasone furoate, fexofenadine (fluticasone furoate, fexofenadine) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid/antihistamine combination. Area: Respiratory/Allergy.

marketed Corticosteroid/antihistamine combination Glucocorticoid receptor (fluticasone furoate); H1 histamine receptor (fexofenadine) Respiratory/Allergy Small molecule Live · refreshed every 30 min

Target snapshot

fluticasone furoate, fexofenadine (fluticasone furoate, fexofenadine) — GlaxoSmithKline. This combination product delivers a corticosteroid that reduces airway inflammation and an antihistamine that blocks allergic responses to treat allergic rhinitis and asthma.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
fluticasone furoate, fexofenadine TARGET	fluticasone furoate, fexofenadine	GlaxoSmithKline	marketed	Corticosteroid/antihistamine combination	Glucocorticoid receptor (fluticasone furoate); H1 histamine receptor (fexofenadine)
Fluticasone/Azelastine nasal spray	Fluticasone/Azelastine nasal spray	University of Chicago	marketed	Intranasal corticosteroid/antihistamine combination	Glucocorticoid receptor; H1 histamine receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid/antihistamine combination class)

GlaxoSmithKline · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). fluticasone furoate, fexofenadine — Competitive Intelligence Brief. https://druglandscape.com/ci/fluticasone-furoate-fexofenadine. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab